Search research articles
Contact Us
Filters
Showing results (31-40 of 160) with videos related to
Page
of 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2026
Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels
Chiara Colombo, Gabriele Tinè, Elena Palassini, et al.
Head & Neck
|
July 29, 2010
Intestinal type adenocarcinoma of the ethmoid sinus in wood and leather workers: a retrospective study of 153 cases
Giulio Cantu, Carlo L Solero, Luigi Mariani, et al.
Cancer
|
May 12, 2007
p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx
Federica Perrone, Luigi Mariani, Elisa Pastore, et al.
Autophagy
|
May 26, 2012
Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage
Nicola Ivan Orlotti, Graziella Cimino-Reale, Erika Borghini, et al.
Annals of Surgical Oncology
|
September 21, 2013
Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought
Sylvie Bonvalot, Nils Ternès, Marco Fiore, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 11, 2002
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases
Elena Tamborini, Viviana Agus, Federica Perrone, et al.
Cancer Biology & Therapy
|
March 13, 2014
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy
Laura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Genes, Chromosomes & Cancer
|
August 13, 2009
Integrative approach for prioritizing cancer genes in sporadic colon cancer
James F Reid, Manuela Gariboldi, Viktorija Sokolova, et al.
Molecular Cancer Therapeutics
|
July 5, 2006
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y)
Marco Ferrone, Federica Perrone, Elena Tamborini, et al.
Oncotarget
|
December 19, 2015
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade
Ilaria Penna, Alessandra Molla, Giulia Grazia, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 160) with videos related to
Sort By:
Page
of 16
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2026
Toremifene in desmoid fibromatosis: Prospective phase 2 study of two dose levels
Chiara Colombo, Gabriele Tinè, Elena Palassini, et al.
Head & Neck
|
July 29, 2010
Intestinal type adenocarcinoma of the ethmoid sinus in wood and leather workers: a retrospective study of 153 cases
Giulio Cantu, Carlo L Solero, Luigi Mariani, et al.
Cancer
|
May 12, 2007
p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx
Federica Perrone, Luigi Mariani, Elisa Pastore, et al.
Autophagy
|
May 26, 2012
Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage
Nicola Ivan Orlotti, Graziella Cimino-Reale, Erika Borghini, et al.
Annals of Surgical Oncology
|
September 21, 2013
Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought
Sylvie Bonvalot, Nils Ternès, Marco Fiore, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 11, 2002
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases
Elena Tamborini, Viviana Agus, Federica Perrone, et al.
Cancer Biology & Therapy
|
March 13, 2014
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy
Laura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Genes, Chromosomes & Cancer
|
August 13, 2009
Integrative approach for prioritizing cancer genes in sporadic colon cancer
James F Reid, Manuela Gariboldi, Viktorija Sokolova, et al.
Molecular Cancer Therapeutics
|
July 5, 2006
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y)
Marco Ferrone, Federica Perrone, Elena Tamborini, et al.
Oncotarget
|
December 19, 2015
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade
Ilaria Penna, Alessandra Molla, Giulia Grazia, et al.
Page
of 16